Sign in to view content

Effects of the Mitochondria-Targeted Drug Elamipretide on Leakage-Independent Vision Loss in Fellow Eyes with Neovascular AMD in the ReCLAIM Study

Priyatham (Prithu) S Mettu, MD

Video
Published 2019

Related

Episode 157: March Retinal Physician Review with Dr. Shriji Patel including discussion of complement inhibition for AMD, faricimab, brolucizimab, and prefilled syringes for injectable medications
Jayanth Sridhar, MD
Member Podcasts
2018
Learnings From the Lampalizumab Chroma and Spectri Phase 3 Trials: Effect of Baseline Characteristics on Geographic Atrophy Progression
Carl D. Regillo, MD
Annual Meeting Talks
2018
Delayed Near Infrared Analysis Identifies Novel Features of Nonexudative Dry Age-Related Macular Degeneration in a Natural History Study: Baseline Findings
Shelley Boyd, MD, FRCS(C)
Annual Meeting Talks
2024

Category: AMD-Non-Neovascular

See more